The 5% organic growth acceleration and 90bps adjusted operating margin expansion are the key signals — they confirm end-market recovery and operational leverage. The stock should gap up on the beat; watch the 8:30am ET call for 2026 guidance updates, which could drive further upside if raised.
Price Chart
Executive Summary
Thermo Fisher reported Q2 2026 revenue of $11.99B (+10% YoY) and adjusted EPS of $6.03 (+13% YoY), beating consensus estimates of $5.71. Organic revenue growth accelerated to 5% from 1% in Q1, with all four segments contributing to the upside. The company did not provide updated guidance in the release, but the strong beat and accelerating organic growth signal improving end-market conditions for this life sciences tools leader.
Key Financial Metrics
Key Facts
- Revenue grew 10% YoY to $11.99B, beating consensus of $11.70B
- Adjusted EPS of $6.03 beat consensus of $5.71 by 5.6%
- Organic revenue growth accelerated to 5% from 1% in Q1 2026
- GAAP operating margin expanded 50bps YoY to 17.4%; adjusted operating margin expanded 90bps to 22.8%
- Free cash flow surged 52% YoY to $1.68B in Q2
- All four segments posted YoY revenue growth, led by Life Sciences Solutions (+13%) and Lab Products & Biopharma Services (+12%)
- Company repurchased $1.0B of stock during the quarter
- Guidance to be provided on the conference call — no update in the press release
Financial Impact
Revenue beat consensus by ~$290M (2.5%); adjusted EPS beat by $0.32 (5.6%)
Risk Factors
- No updated 2026 guidance provided in the release — conference call commentary is the next catalyst
- GAAP operating cash flow declined sequentially from Q1 ($1.19B to $1.13B on a standalone Q2 basis), though H1 total is strong
- Restructuring costs of $98M in Q2 vs $82M a year ago — elevated but manageable
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000097745-26-000138 |
| Document: tmo-20260723.htm | 0000097745-26-000138 |
| Document: 0000097745-26-000138-index-headers.html | 0000097745-26-000138 |
| Document: 0000097745-26-000138-index.html | 0000097745-26-000138 |
| Document: 0000097745-26-000138.txt | 0000097745-26-000138 |
| 8-K Data (Synthetic) | 0000097745-26-000138 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | Insider Cluster | $600.50 $675.05 | ▲ +12.41% | ▲ +12.30% | $650.08 (+8.26%) |
Aug 26, 2026 5w ago | Insider Cluster | $630.70 $666.33 | ▲ +5.65% | ▲ +5.75% | $650.08 (+3.07%) |
Aug 24, 2026 5w ago | Insider Cluster | $628.74 $658.52 | ▲ +4.74% | ▲ +3.42% | $650.08 (+3.39%) |
Aug 18, 2026 6w ago | Court Ruling | $589.04 $648.43 | ▲ +10.08% | ▲ +11.39% | $650.08 (+10.36%) |
Aug 13, 2026 7w ago | Insider Cluster | $588.29 $613.62 | ▲ +4.31% | ▲ +6.30% | $650.08 (+10.50%) |
Aug 10, 2026 7w ago | Insider Cluster | $605.00 $605.69 | ▲ +0.11% | ▲ +1.17% | $650.08 (+7.45%) |
Aug 7, 2026 8w ago | Insider Cluster | $594.00 $613.78 | ▲ +3.33% | ▲ +3.73% | $650.08 (+9.44%) |
Jul 23, 2026 10w ago | 8-K | $572.32 $627.55 | ▲ +9.65% | ▲ +6.34% | $650.08 (+13.59%) |
Jun 11, 2026 16w ago | ANALYST-UPGRADE | $469.34 $527.05 | ▲ +12.30% | ▲ +10.52% | $650.08 (+38.51%) |
Jun 11, 2026 16w ago | Institutional Cluster | $475.66 $524.71 | ▲ +10.31% | ▲ +8.42% | $650.08 (+36.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access